MET-mediated phosphorylation of YANK2 at Y282 inhibits NEDD4L-dependent SUMOylation and degradation, promoting chemoresistance in glioblastoma.

Shi Y, Cheng Y, Li W, Zhu A, Xiao J, Wang W, Tang L, Zhao S, Lee MH, Malyarenko OS, Duan Q

DOI: 10.1186/s43556-026-00496-3
Published: 2026 Jun 24
Container: Molecular biomedicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s43556-026-00496-3,
  title = {MET-mediated phosphorylation of YANK2 at Y282 inhibits NEDD4L-dependent SUMOylation and degradation, promoting chemoresistance in glioblastoma.},
  author = {Shi Y and Cheng Y and Li W and Zhu A and Xiao J and Wang W and Tang L and Zhao S and Lee MH and Malyarenko OS and Duan Q},
  year = {2026},
  journal = {Molecular biomedicine},
  doi = {10.1186/s43556-026-00496-3},
  url = {https://doi.org/10.1186/s43556-026-00496-3}
}

RIS

TY  - JOUR
TI  - MET-mediated phosphorylation of YANK2 at Y282 inhibits NEDD4L-dependent SUMOylation and degradation, promoting chemoresistance in glioblastoma.
AU  - Shi Y
AU  - Cheng Y
AU  - Li W
AU  - Zhu A
AU  - Xiao J
AU  - Wang W
AU  - Tang L
AU  - Zhao S
AU  - Lee MH
AU  - Malyarenko OS
AU  - Duan Q
PY  - 2026
JO  - Molecular biomedicine
DO  - 10.1186/s43556-026-00496-3
UR  - https://doi.org/10.1186/s43556-026-00496-3
ER  -

APA

Y, S., Y, C., W, L., A, Z., J, X., W, W., L, T., S, Z., MH, L., OS, M., & Q, D. (2026). MET-mediated phosphorylation of YANK2 at Y282 inhibits NEDD4L-dependent SUMOylation and degradation, promoting chemoresistance in glioblastoma.. Molecular biomedicine. https://doi.org/10.1186/s43556-026-00496-3

Source records

pubmed · retrieved 2026-09-26T13:53:15.663Z